Japanese Webinar: Next-Generation Drug Discovery Unlocked by Organoids

Automating the culture of 3D tissue models! Enhancing the reliability and reproducibility of assays, significantly reducing human error, and improving the productivity of the cell culture process.

Organoids derived from iPS cells and tissue stem cells are expected to serve as advanced in vitro models for disease modeling and drug screening, as they mimic human tissue structure and function, thereby improving the clinical predictability of drug responses. However, challenges such as the complexity of sample preparation, reproducibility, and scalability hinder their practical application as a major screening method in drug discovery. To address this bottleneck in sample preparation, our product does not perform mechanical operations regularly; instead, AI machine learning automatically makes decisions based on monitoring results of the samples. Under a 24-hour operational environment, it appropriately conducts and manages medium exchanges and passaging, fully automating the complex workflow of the organoid culture process. As a result, we achieve significant reductions in costs and time, as well as a decrease in human error, while enhancing the productivity of the cell culture process in assays using iPS cells and organoids. *For detailed specifications, please refer to the PDF document or feel free to consult us.*

• Other Culture

A high-content screening system that employs industry-leading cameras, significantly improving sensitivity and resolution.

"ImageXpress HCS.ai" is a high-content screening system that inspires users' imagination with high-quality imaging and analysis, enabling them to easily obtain the data they need. It can be configured to meet the requirements of users and can be upgraded to adapt to the evolving needs of research. Empower your team to obtain high-resolution images and robust data from various 2D and 3D cell assays, and leverage the power of AI to gain deeper insights. 【Features】 ■ Addresses future lab needs ■ Access to insightful data ■ Ability to capture details of 2D and 3D biological models ■ Capability to gain deeper insights ■ Ability to obtain clearer images more quickly ■ Everything from image acquisition to data analysis can be done on a single platform *For more details, please download the PDF or feel free to contact us.

• Other inspection equipment and devices

The organoid technology is gaining prominence in drug discovery research. We will hold a Japanese webinar where you can learn about the automation of culture through AI image analysis and the reduction of drug discovery risks through the utilization of multimodal data, all in one session. We will introduce technologies that quantify organoid culture using AI image analysis, enabling autonomous passaging decisions, as well as the latest examples of data utilization that integrate multi-omics data from patient-derived organoids (PDOs) to predict drug responses with high accuracy, thereby reducing drug discovery risks. These advancements are expected to enhance research reproducibility and promote precision medicine. A Q&A session is also planned after the presentations. Presentation 1: Automation of organoid culture through quantification of culture conditions and autonomous passaging decisions using AI image analysis Koji Utagawa, Application Scientist, Molecular Devices Japan, Ph.D. in Science Presentation 2: Risk reduction in cancer drug projects using molecular and multi-omics data from organoids Toshiya Kondo, Scientific Business Consultant, Genedata AG, M.D.

[Instructor] Shunsuke Suzuki, President and CEO, Management Techniques Co., Ltd. [Key Lecture Content] In a rapidly changing business environment, we are compelled to collaborate with people from various backgrounds every day and to push our proposals and ideas through amidst the intersection of diverse opinions and values. However, for some reason, good ideas are often not understood or accepted. Why is that? To implement new initiatives within an organization, it is necessary to overcome multiple barriers and unify stakeholders with differing opinions and values. In this seminar, we will explain a "management theory" that has not been commonly addressed, based on various perspectives such as organizational theory, psychology, communication theory, and political economy. We will cover communication techniques that promote changes in people's behaviors and attitudes, storytelling that generates empathy, and the building of trust relationships, all aimed at achieving transformation within organizations. This will be beneficial not only for proposals within organizations but also for improving interpersonal skills in a wide range of situations, including BtoB sales negotiations and the building of everyday human relationships.

[Speaker] Kazunori Kitagawa, Director of Eco-Management Center, Japan Productivity Center for Socio-Economic Development [Key Lecture Content] European circular economy policies are poised to have a significant impact on the automotive industry. In particular, the regulations on end-of-life vehicles scheduled to be issued this year may necessitate fundamental reforms in raw material procurement, information collaboration, and product recycling related to the manufacturing and resource circulation of automobiles in the future. This lecture will explain the policy trends related to these regulations, an overview of the system, countermeasures, trends among European manufacturers, management of recycled material procurement, and the upcoming timeline. [Lecture Topics] 1. Policy trends of the circular economy in the EU 2. Transition from recycling to resourcing in the EU End-of-Life Vehicle Directive and regulation amendments 3. Supply chain management related to the supply of recycled plastics 4. Overview of the End-of-Life Vehicle Regulation bill 5. Current status of circular economy business models among European automobile manufacturers 6. Future challenges and countermeasures 7. Q&A / Business card exchange *The content of the lecture may change based on the latest trends.

[Speaker] President and CEO of ICT Solutions Consulting Co., Ltd. / Creator, Takashi Tominaga [Lecture Topics] 1. The era where past common sense becomes nonsense - The AI industrial revolution accelerated by Trump - What are disrupter companies? - What is considered nonsense? - How past common sense has become nonsense 2. The impact destroying various industries and the remaining time - What is happening in the defense industry - What is happening in the financial industry - What is happening in the manufacturing industry 3. What is different? - Thinking like a disrupter (e.g., Elon Musk) - How to compete with disrupters 4. Towards survival - How to survive by 2030 5. Q&A / Business card exchange

Daitron Corporation will be exhibiting at "BATTERY JAPAN International Secondary Battery Expo" held at Tokyo Big Sight. This exhibition showcases all the technologies, components, materials, and equipment necessary for the research, development, and manufacturing of secondary batteries, attracting experts from around the world. Additionally, the exhibition content will be available online. < Online exhibition period: March 10, 2026 (Tuesday) to May 15, 2026 (Friday) > We invite customers who find it difficult to visit the venue to join our online exhibition.